CalciMedica

Q2 FY2026 EarningsQ2 FY26 results missed consensus estimates across key profitability metrics despite maintaining zero revenue in line with expectations. GAAP net loss was $7.7M vs. the $5.5M expected, while GAAP EPS of -$0.45 missed the -$0.29 consensus. The miss was primarily driven by a $3.6M non-cash charge related to the change in fair value of financial instruments, overshadowing a 48% YoY reduction in total operating expenses. Management expects current cash to fund operations into H2 2027, supported by a recent $49M private placement.